Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WATERFALL: Aggressive vs Moderate Fluid Resuscitation in Acute Pancreatitis
NCT04381169Phase 3Terminated
- Start
- May 2020
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lactated ringer's solution in acute pancreatitis (AP) (2 arms). Primary endpoint: Moderate-to-severe acute pancreatitis up to 24 weeks. Started May 2020; status: terminated.
02
Drugs
lactated ringer's solution
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT04381169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04381169.